Pancreatic Cancer
FEATURES
avatar
1732 clinical trials
avatar
318 cell line models
avatar
10 approved drugs
IMAGE
Pancreatic Cancer
Molecular Synopsis
OVERVIEW
Drugs and clinical candidates

10 drugs have received FDA approval for Pancreatic Cancer:

  • /LU
  • Erlotinib Hydrochloride
  • Everolimus
  • Fluorouracil
  • Gemcitabine Hydrochloride
More

293 drugs have a clinical trial registered for Pancreatic Cancer.

2330 compounds have been tested in Pancreatic Cancer (1635 <= 500nM potency).

Sources: cancer.gov, clinicaltrials.gov, ChEMBL.

Clinical trials
There are 1732 clinical trials for Pancreatic Cancer, 1048 of which have one or more drug interventions, 684 with no drug intervention.
Cell line models

There are 318 Cell Line Models for Pancreatic Cancer.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Pancreatic Cancer:
  • Carcinoma, Pancreatic Ductal
  • Pancreatic Intraductal Neoplasms
  • Pancreatic Neoplasms
The following terms have been mapped from cancer.gov to Pancreatic Cancer:
  • Pancreatic cancer that has metastasized. It is used with gemcitabine hydrochloride
  • Pancreatic cancer
  • Pancreatic cancer that is advanced or has metastasized. It is used in patients whose disease cannot be removed by surgery and who have already been treated with other chemotherapy. It is used with paclitaxel albumin-stabilized nanoparticle formulation
  • Gastroenteropancreatic neuroendocrine tumors. It is used in some patients whose tumors cannot be removed by surgery, are locally advanced, or have metastasized (spread to other parts of the body)
  • Pancreatic cancer. It is used in patients with progressive neuroendocrine tumors that cannot be removed by surgery, are locally advanced, or have metastasized (spread to other parts of the body)
More